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Abstract
 
The T helper (Th) cell pool is composed of specialized cells with heterogeneous effector func-
 
tions. Apart from Th1 and 2 cells, CXCR5
 
 
 
 T cells have been suggested to be another type of
effector T cell specialized for B cell help. We show here that CXCR5
 
 
 
 T cells are heteroge-
neous, and we identify subsets of CXCR5
 
  
 
CD4 T cells that differ in function and microenvi-
ronmental localization in secondary lymphoid tissues. CD57
 
 
 
CXCR5 T cells, hereafter
termed germinal center Th (GC-Th) cells, are localized only in GCs, lack CCR7, and are
highly responsive to the follicular chemokine B lymphocyte chemoattractant but not to the T
cell zone EBI1-ligand chemokine. Importantly, GC-Th cells are much more efficient than
CD57
 
 
 
CXCR5
 
 
 
 T cells or CXCR5
 
 
 
 T cells in inducing antibody production from B cells.
Consistent with their function, GC-Th cells produce elevated levels of interleukin 10 upon
stimulation which, with other cytokines and costimulatory molecules, may help confer their B
cell helper activity. Our results demonstrate that CXCR5
 
 
 
 T cells are functionally heteroge-
neous and that the GC-Th cells, a small subset of CXCR5
 
 
 
 T cells, are the key helpers for B
cell differentiation and antibody production in lymphoid tissues.
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Introduction
 
CD4 Th cells are composed of naive T cells and function-
ally heterogeneous memory T cell subsets at various differ-
entiation stages (1–3). Naive CD4 T cells originate in the
thymus and are developmentally programmed to home to
secondary lymphoid tissues (4). After activation by APCs,
vigorous proliferation and maturation of CD4 T cells occur
in the secondary lymphoid tissues, generating antigen-spe-
cific memory T cells. In contrast to naive cells, some mem-
ory cells home well to nonlymphoid tissues. However,
many memory T cells can also home to secondary lym-
phoid organs, but the functional significance of these differ-
ent homing subsets is only now being elucidated.
Lymphocyte homing from blood to organs or tissues and
movement from one microenvironment to another are
controlled at multiple levels (4, 5). These include initial in-
teractions of lymphocyte adhesion molecules and their re-
ceptors on endothelial cells for rolling, chemokine-induced
cell arrest through integrin activation, diapedesis, and
chemotaxis to specific microenvironments within tissues,
and adhesive interactions with stromal cells and extracellu-
lar matrix components. Chemokines expressed in specific
microenvironments and conditions play important roles in
the regulation of leukocyte trafficking for homeostasis and
during progression of immune response (6–10). Secondary
 
lymphoid tissue chemokine (SLC),
 
1
 
 also called CCL21,
Exodus2, 6Ckine, or TCA-4, expressed on high endothe-
lial venules, and its receptor CCR7, participate in recruit-
ing T cells to secondary lymphoid tissues (11–13). Along
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with another ligand of CCR7, EBI1-ligand chemokine
(ELC, also called CCL19/CK
 
 
 
-11/MIP-3
 
 
 
), SLC may
also help define boundaries of T and B cell zones in sec-
ondary lymphoid tissues (13–18). Both CCR7-deficient
mice and plt mice, which apparently lack functional lym-
phoid organs SLC and ELC, display abnormal localization
of lymphocytes in secondary lymphoid tissues and impaired
immune responses, further implicating the T cell zone
chemokines and their receptor CCR7 in lymphocyte hom-
ing to the lymphoid organs and immunity (19, 20).
Circulating B cells also home to secondary lymphoid
tissues in search of trapped antigens. Unlike T cells,
chemokines that trigger B cell arrest on high endothelial
venules and diapedesis into the secondary lymphoid organs
remain to be characterized (11). After entry into lymphoid
tissues, homing B cells localize in follicles that are sepa-
rated from, but adjacent to, the T cell zones. After stimu-
lation, antigen-specific T and B cells initially interact at the
edges of the follicles via their surface receptors and the cy-
tokines they secrete (21, 22). Some B cells differentiate at
this stage into short-lived antibody-forming cells, but
other activated B cells and antigen-specific T cells migrate
into the follicles where they form germinal centers (GCs).
In GCs, B cells undergo rapid clonal expansion, somatic
hypermutation, isotype switching, and clonal selection
(23). Surface receptors on B cells such as CD40, OX40L,
and cytokine receptors play important roles in receiving
the signals from T cells required for the GC reaction (24).
The chemokine receptor CXCR5 is expressed on B cells
and required for development of follicles in some second-
ary lymphoid tissues as well as for B cell localization in the
follicles of spleens and Peyer’s patches (25). The CXCR5
ligand B lymphocyte chemoattractant (BLC) is expressed
by stromal cells (most likely follicular dendritic cells) in B
cell follicles and is one of the strongest B cell chemoattrac-
tants (26–28). BLC is required for B cell migration to fol-
licles in lymph nodes and spleen (29). Interestingly,
CXCR5 is also expressed on a subset of circulating human
memory CD4 T cells (30) and is upregulated on some an-
tigen-responding mouse CD4 T cells after immunization
(31). Thus, expression of CXCR5 provides a possible
mechanism for T cells to enter the B cell follicles and may
be an important marker for a specialized subset of CD4 T
cells for helping B cells.
In line with this, it has been recently reported that
CXCR5 defines Th cells with B cell helper function (32,
33). In contrast with these reports, we demonstrate that
CXCR5 alone does not define B cell helpers in either lym-
phoid tissue or circulation. Instead, CXCR5
 
 
 
 T cells are
actually heterogeneous and in tonsils only a small subset of
CXCR5
 
 
 
 T cells, specifically found in GCs, effectively
stimulates B cell antibody production. Unlike the GC
CXCR5
 
 
 
 T cells, circulating CXCR5
 
 
 
 T cells are resting
and thus need to be activated to help B cells. T cell recep-
tor stimulation can induce B cell helper activity in blood
CXCR5
 
 
 
 T cells but also in CXCR5
 
 
 
 T cells. Therefore,
CXCR5 expression by itself does not imply specialization
for B cell helper activity.
 
Materials and Methods
 
Antibody and Cytokines.
 
Antibodies to the following antigens
were obtained from BD PharMingen unless indicated other-
wise: CD3 (UCHT1); CD4 (RPA-T4); CD19 (HIB19); CD27
(M-T271); CD28 (CD28.2); CD45RA (HI100); CD45RO
(UCHL1); CD57 (NK-1); CD69 (CH/4; Caltag); CD134
(ACT35); IL-2 (MQ1-17H12); IL-4 (3010.211; Becton Dickin-
son); IL-5 (JES1-39D10); IL-10 (JES3-19F1); IL-12 (C11.5); IL-
13 (JES10-5A2); IFN-
 
 
 
 (4S.B3); TNF-
 
 
 
 (mAb11); TNF-
 
 
 
(359.81.11); CLA (HECA 452; E.C. Butcher’s laboratory);
CD62L (DREG-200; E.C. Butcher’s laboratory); 
 
 
 
4
 
 
 
7 (ACT-1;
LeukoSite); CCR7 (7H12-12-2; LeukoSite); CXCR5 (51505.111;
R&D Systems); and CD154 (24-31; Ansell Corp.). Cytokines,
IL-2, IL-4, and IL-12 were purchased from BD PharMingen.
The following chemokines were from PeproTech, Inc., unless
indicated otherwise: SLC; stromal cell–derived factor (SDF)-1;
MIP-3
 
 
 
; TARC; IP-10 (R&D Systems); and BLC (B cell–attract-
ing chemokine [BCA]-1; I. Clark-Lewis’ laboratory).
 
Cell Isolation.
 
PBMCs from human peripheral blood (Stan-
ford University Blood Center, Stanford, CA) were prepared by
density gradient centrifuge on histopaque 1077 (Sigma-Aldrich).
Tonsil CD4 T cells were isolated from human tonsils obtained
from young patients (3–10 yr) undergoing tonsillectomy to re-
lieve obstruction of respiratory passages and improve drainage of
the middle ear. Untouched CD4
 
 
 
 T cells (purity 
 
 
 
97%) were
isolated by depleting non-CD4
 
 
 
 T cells using a magnetic bead
depletion method (Miltenyi Biotec). After staining of the isolated
CD4 T cells with appropriate antibodies, CD57
 
 
 
/
 
 
 
 and/or
CXCR5
 
 
 
/
 
 
 
 naive and memory cells were sorted using FACS-
Vantage™ SE (Becton Dickinson). Sorted CD4 T cell subsets
were on average 99% pure. B cells were isolated from the low
density PBMCs or tonsils using CD19 beads (Dynal, Inc.) and
detached from the beads according to the manufacturer’s proto-
col. Isolated CD19
 
 
 
 peripheral blood B cells were stained with
anti-CD19 and anti–IgD antibodies and further sorted by FACS-
Vantage™ to isolate naive CD19
 
 
 
IgD
 
 
 
 
 
and memory CD19
 
 
 
IgD
 
 
 
 B cells (purity 
 
 
 
99%).
 
Immunohistochemistry.
 
Frozen sections of tonsils were stained
using directly labeled antibodies and/or three-step streptavidin-
biotin staining for CXCR5. In brief, acetone-fixed sections were
stained with the primary monoclonal antibody to CXCR5
(R&D Systems), followed by incubation in biotinylated goat
anti–mouse IgG (Vector Laboratories). After incubation with
streptavidin-PE and directly labeled antibodies to CD57 (FITC
labeled; BD PharMingen), CD4 (APC; Caltag), and/or IgD-PE
(BD PharMingen) in 10% mouse serum, the sections were ob-
served under a confocal microscope (MRC 1024ES; Bio-Rad
Laboratories).
 
Chemotaxis Assay.
 
Isolated blood or tonsil CD4
 
 
 
 T cells (10
 
6
 
cells per well) were used as input cells for chemotaxis assay.
Transwells (5-
 
 
 
m pore size; Corning, Inc.) were used to mea-
sure chemotactic responses of various T cell subsets. Cells were
allowed to migrate for 3 h. Input cells and cells migrated to the
lower chambers were stained with antibodies to CXCR5,
CD57, and CD4 and counted using FACSCalibur™ (Becton
Dickinson) as described previously (16). 15-
 
 
 
m beads (Poly-
sciences, Inc.) were used as counting standards, and data were
presented as the percentage of migration of each cell subset in the
input cells.
 
Cytokine Expression (Intracellular Staining and ELISA).
 
The sorted
cells (CD45RA
 
 
 
CXCR5
 
 
 
, CD45RA
 
 
 
CXCR5
 
 
 
, and CD45RA
 
 
 
CXCR5
 
 
 
 cells) were activated for 4.5 h at 37
 
 
 
C with 50 ng/ml
PMA and 1 
 
 
 
g/ml ionomycin in RPMI 1640 supplemented with 
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Figure 1. Identification of CD57 
CXCR5  T cells and their localiza-
tion in GCs. (A) Flow analyses of
CD57 and CXCR5 expression on
tonsil CD4 T cells. (B) Specific lo-
calization of CD57  CD4 T cells in
GCs. (C) Localization of CD57 
CXCR5  CD4 T cells in GCs. An-
tibodies to CD57 (green), CD4
(blue), and IgD (red; B) or CXCR5
(red; C) were used for in situ immu-
nohistochemistry.
 
penicillin/streptomycin, 10% fetal bovine serum, and 1 
 
 
 
g/ml
brefeldin A (Sigma-Aldrich). For experiments in Figs. 3 A and 5 B,
isolated CD4 T cells were prestained with antibodies (anti-
CXCR5, anti-CCR7, anti–CD57-FITC, and/or anti–CD45RA-
Tricolor) and activated with PMA and ionomycin in the presence
of 10 
 
 
 
g/ml monensin (Sigma-Aldrich). This prestaining method
yielded similar results to FACS
 
®
 
 sorting followed by activation.
Activated cells were fixed and permeabilized using cytofix/cyto-
perm solution (BD PharMingen) and stained with phycoerythrin-
conjugated isotype control antibodies or monoclonal antibodies
to IL-2, IL-4, IL-5, IL-10, IL-12, IL-13, IFN-
 
 
 
, TNF-
 
 
 
, and
TNF-
 
 
 
. In preliminary experiments, these antibodies were tested
on in vitro–generated polarized Th1 and 2 CD4 T cells (34).
Data were analyzed on FACSCalibur™ using CELLQuest™
(Becton Dickinson). Supernatants of activated tonsil T cells (10
 
5
 
cells per well in 96-well plates) by 50 ng/ml PMA and 1 
 
 
 
g/ml
ionomycin for 24 h were assayed for IL-4, IL-10, and IFN-
 
 
 
 us-
ing ELISA kits (Quantikine; R&D Systems) according to the
manufacturer’s protocols.
 
T–B Cell Coculture and ELISA of Antibody Production.
 
Sorted ton-
sil CD57
 
 
 
CXCR5
 
 
 
, CD57
 
 
 
CXCR5
 
 
 
, and CXCR5
 
 
 
 T cells
(10
 
5
 
) were cultured for 11–13 d in 96-well plates with an equal
number of isolated B cells from the same tonsil. For blood T cells,
various numbers of sorted T cells (10
 
3
 
, 5
 
   
 
10
 
3
 
, 10
 
4
 
, 2.5
 
   
 
10
 
4
 
, 5
 
  
 
10
 
4
 
, and 10
 
5
 
) were cultured for 14 d in anti-CD3–coated round-
bottomed 96-well plates containing B cells from the same donors
(2
 
   
 
10
 
4
 
), 2 
 
 
 
g/ml anti-CD28, and 10% fetal bovine serum in
RPMI 1640. 96-well ELISA plates (Corning, Inc.) were coated
with 100 
 
 
 
l of anti–human IgG, IgM, or IgA goat polyclonal an-
tibodies (Kirkegaard & Perry Lab) at 10 
 
 
 
g/ml in PBS overnight
 
at 4
 
 
 
C. The plates were extensively washed with PBS and then
blocked at 37
 
 
 
C for at least 0.5 h with blocking buffer (1% BSA,
0.05% Tween 20,
 
 
 
1
 
  
 
PBS). Culture supernatants and standard
antibodies were diluted and added to the coated wells. After 2 h,
plates were washed with PBS before incubation for an additional
2 h with peroxidase-conjugated goat polyclonal antibodies to hu-
man IgG, IgM, or IgA (final 1 
 
 
 
g/ml in PBS; Kirkegaard & Perry
Lab). After extensive washing with PBS, plates were developed
with developing solution (
 
O
 
-phenylenediamine dihydrochlo-
ride; Sigma-Aldrich) and read with an ELISA reader at OD 490.
 
Results
 
A Subset of CXCR5
 
  
 
CD4 T Cells Expresses CD57 and Is
Specifically Localized in the GCs of Tonsils.
 
As in blood,
both naive CD45RO
 
 
 
 (or CD45RA
 
 
 
) and memory type
CD45RO
 
 
 
 (CD45RA
 
 
 
) T cells are found in tonsils.
While most naive T cells in tonsils do not express CXCR5,
 
 
 
90% of tonsil memory type CD4 T cells express CXCR5
(Fig. 1 A), a frequency much higher than peripheral blood
CD4 T cells ( 20% of memory T cells in blood are
CXCR5 ). CD57 is an antigen associated with GCs (35,
36) and expressed on a subset of CD4 T cells that are posi-
tive for CD69 and CD45RO (37). Expression of CD57
subdivides tonsil CXCR5  CD4 T cells into two popula-
tions (Fig. 1 A). CD57 expression is detected only on 15–
25% of tonsil CXCR5  CD4 T cells but is not seen on
CXCR5  or naive CD4 T cells. We examined localization1376 Differentiation and Specialization of CXCR5  CD4 T Cells
of these CXCR5  CD4 T cell subsets in tonsil by im-
munohistochemistry and confocal microscopy. CD57 
CXCR5  T cells are abundant in GCs but not in primary
follicles of IgD  B cells or in the interfollicular/T cell area
(Fig. 1, B and C). In contrast, as reported previously by
Forster et al. (30), CXCR5  CD4 T cells are found not
only in B cell follicles but, in great numbers, in the inter-
follicular/T cell area (Fig. 1 C). Their differential local-
ization within lymphoid tissues suggests that the two
CXCR5  T cell populations have distinct functions.
CD57 CXCR5  T Cells Are Highly Responsive to BCA-
1/BLC but Not Responsive to ELC. In an effort to under-
stand the differential localization of tonsil CD4 T cell sub-
sets, we examined the chemotactic response of tonsil CD4
T cell subsets to the follicular chemokine BCA-1/BLC and
to a T cell area chemokine ELC. A general chemoattractant
SDF-1 was also included in this assay. CD57 CXCR5  T
cells demonstrate a greater chemotactic response to BLC
than CD57 CXCR5  T cells, and unlike the CD57 
CXCR5  subset, do not significantly respond to the T cell
area chemokine ELC (Fig. 2 A). Reduced response to ELC
is thought to be important to allow T cells to enter the
GCs (38). Both CD57  and CD57 CXCR5  T cells are
highly responsive to SDF-1. CXCR5  CD4 T cells do not
respond to BLC but respond vigorously to ELC and SDF-1.
Consistent with their chemotactic responses, the ELC re-
ceptor CCR7 is not expressed on CD57 CXCR5  T cells
but on a subset of CD57 CXCR5  T cells and on most
CXCR5  T cells (Fig. 2 B). Thus, their chemotactic re-
sponses and chemokine receptor expression pattern corre-
late with the specific localization of CD57 CXCR5  T
cells in GCs.
Effector Machinery of CD57 CXCR5  T Cells. Next, we
examined cytokine production by different T cell subsets
from tonsils. Similar frequencies of TNF- , IL-4, and IFN- 
producers are found in CD57  and CD57  memory CD4
T cells (Fig. 3 A). However, one notable difference be-
tween these T cell populations is that the CD57  T cells
are more efficient in production of IL-10 as evidenced by
intracellular staining (Fig. 3 A) and ELISA (Fig. 3 B). On
the other hand, naive or CXCR5  T cells did not or very
poorly produce IL-10, IL-4, and IFN- , and contained
lower frequencies of IL-2 and TNF-  producers than ei-
ther memory or CXCR5  subset. OX40 and CD40L are
inducible T cell antigens of the TNF receptor–TNF ligand
family that play important roles in B cell help and antibody
switching (39, 40). Therefore, we examined expression of
these molecules by the tonsil T cell subsets before and after
brief (1–3 h) stimulation with PMA and ionomycin. While
the two CXCR5  T cell populations are much more effi-
cient than CXCR5  T cells in upregulation of surface
OX40 and CD40L after stimulation, no notable difference
between the CD57  and CD57 CXCR5  T cells was found
(data not shown).
Only the CD57  Subset of Tonsillar CXCR5  T Cells Effi-
ciently Helps B Cells Produce Antibodies. To determine the
efficiency of CD57- and CXCR5-defined T cell subsets in
helping B cells produce antibody, sorted tonsil CD57 / 
CXCR5 /  CD4 T cells were cultured with CD19  B
cells from the same tonsils followed by ELISAs of secreted
IgG, IgA, and IgM. Strikingly, the CD57 CXCR5  T
cells very efficiently induced B cell production of all three
isotypes examined, while the CD57 CXCR5  T cells,
which account for the majority ( 80%) of tonsil CXCR5 
T cells, only weakly induced antibody production (Fig. 4).
Indeed, they were little or no more efficient than
CXCR5  T cells in providing B cell help.
Phenotype of Blood CXCR5  T Cells. In blood only
 20% of memory T cells are CXCR5 . Most blood
CXCR5  T cells are CD57 CD27 CD45RAlow/  (Fig. 5
A). The majority of them are CD62L , CCR7 , and
CLA . Additionally, 20–25% of CXCR5  T cells are
 4 7  cells. This pattern of adhesion and chemokine re-
ceptor expression suggests that the blood CXCR5  T cells
home to peripheral and mucosal lymphoid tissues. In con-
trast to the CXCR5  memory T cells, fewer CXCR5  T
cells from blood produce the Th1/2 effector cytokines IL-4
and IFN- , even after repeated stimulation with anti-CD3
and anti-CD28 (Fig. 5 B). Expression of other cytokines
such as IL-5, IL-10, IL-12, and TNF-  was not readily de-
Figure 2. Chemotactic responses (A) and chemokine receptor expres-
sion (B) by CD57   CXCR5 /  CD4 T cells. Optimal concentrations of
5  g/ml BLC, 1  g/ml ELC, and 100 ng/ml SDF-1 were used for
chemotaxis experiments. Freshly isolated tonsil cells were used for
chemotaxis and flow analyses of tonsil CD4 T cell subsets. Representa-
tives of three independent experiments are shown.1377 Kim et al.
tected in the circulating CXCR5  T cell population (data
not shown).
CXCR5 Is Not a Specific Maker for B Cell Helpers in
Blood. Although blood CXCR5  cells may be able to
home to B cell follicles in lymphoid tissues, it is known
that, unlike the tonsil GC CXCR5  T cell studied above,
these resting blood T cells (which neither express surface
costimulatory molecules nor secrete effector cytokines)
cannot constitutively support B cell antibody production.
However, B helper activity can be induced in blood T cells
by appropriate stimulation (41, 42). To determine if
CXCR5 expression correlates with enhanced potential for
B cell help, sorted peripheral blood CXCR5  and
CXCR5  memory and naive CD4 T cells were cultured in
the presence of anti-CD3 and anti-CD28 with isolated pe-
ripheral blood B cells. Secreted IgG, IgA, and IgM in cul-
ture media were quantified by ELISA. Cultures of B cells
alone or with stimulated naive T cells did not produce sig-
nificant levels of antibodies (Fig. 5 C). In contrast, both cir-
culating CXCR5  and CXCR5  memory T cells induced
B cell production of IgG, IgA, and IgM. Thus, CXCR5
expression neither predicts constitutive B helper capacity
nor indicates a special potential to provide B cell help. In-
terestingly, when activated with anti-CD3 and anti-CD28,
CXCR5  T cells lose surface CXCR5 expression and be-
come CXCR5  T cells within 3 d (Fig. 5 D). Thus, the
circulating CXCR5  cells with B cell helping function
could be originated from CXCR5  T cells in vivo.
Figure 3. Effector machinery of CD57 / CD45RA /  or CD57 / 
CXCR5 /  CD4 T cells. (A) Intracellular cytokine analyses of TNF- ,
IL-2, IL-10, IFN- , and IL-4. (B) ELISA of IL-10 and IL-4. Isolated T
cells were activated with 50 ng/ml PMA and 1  g/ml ionomycin for 4 h
for intracellular cytokine analyses, or 24 h for ELISA of IL-10 and IL-4.
Representatives of at least four independent experiments are shown.
Figure 4. Spontaneous B
cell helper activity of CD57 / 
CXCR5 /   CD4 T cells.
Sorted CD57 CXCR5 , CD57 
CXCR5 , and CXCR5  CD4
T cells were cocultured with B
cells from the same tonsil for
11–13 d in the absence of any
stimulatory agents followed by
analyses of secreted IgG, IgA,
and IgM. Representatives of at
least three independent experi-
ments are shown.1378 Differentiation and Specialization of CXCR5  CD4 T Cells
Discussion
CD57 CXCR5  T Cells Are the B Cell Helper T Cells
within the Tonsil CXCR5  T Cell Population. Thus far, im-
munologists have believed that effector CD4 T cells exist
mainly in two forms: Th1 or Th2 cells. Indeed, this Th1/2
paradigm provides convincing explanations for pathological
progression of many polarized inflammatory diseases. Also
it has been believed that Th cells for B cell differentiation
are contained within these Th1/2 populations. However,
almost all circulating Th1/2 cells lack expression of
CXCR5, a molecule thought to be necessary (but not suf-
ficient) for homing to B cell areas of lymphoid tissues. Re-
cent reports indeed suggest that lymphoid tissue homing
CXCR5  T cells are a new third type of T follicular helper
effector cell specialized for B cell help (32, 33, 43). How-
ever, the fact that these CXCR5  T cells are extraordinar-
ily abundant in tonsils, constituting the majority of total
memory T cells, and are found not only in follicles but also
in interfollicular areas/T cell zones, prompted us to exam-
ine this hypothesis further. Our results demonstrate that
CXCR5  T cells are functionally heterogeneous and that
the majority of CXCR5  T cells are neither capable nor
clearly specialized for providing efficient B cell help. We
identify the efficient B cell helping effector T cells,
CD57 CXCR5 T cells, hereafter termed GC T helper
(GC-Th) cells, as a small subset of CXCR5  T cells that
are localized in GCs and display the surface phenotype:
CD4 CD45RO CD57 CXCR5  CCR7 .
GC-Th cells account for only 15–25% of total CXCR5 
T cells in tonsils and are specifically localized in GCs, while
other CXCR5  T cells are found scattered in B cell folli-
Figure 5. Phenotype and effector function of circulating
CXCR5  T cells. (A) Surface phenotype of circulating na-
ive or CXCR5 /  memory T cells. **Significant differ-
ences between CXCR5  and CXCR5  memory cells. (B)
IL-4/IFN-  production capabilities of CXCR5 /  T cells
during repeated T cell receptor activation (each cycle is
composed of 4-d activation with anti-CD3 and anti-CD28
followed by 3-d resting in the presence of IL-2). (C) B cell
help activity of circulating CXCR5  T cells after T cell re-
ceptor activation. Naive (IgD ) or memory (IgD ) B cells
(2   104) from peripheral blood were cultured for 14 d in
the presence or absence of various numbers (103, 5   103,
104, 2.5   104, 5   104, and 105) of autologous T cells
(CXCR5 CD45RA , CXCR5 CD45RA , or CXCR5 
CD45RA ). Concentrations of IgG, IgA, and IgM in the
culture supernatants were measured by ELISA. T cell num-
bers required for peak levels of antibody production varied among donors or experiments. One peak value with the best antibody production in each T
cell group is shown. (D) Loss of CXCR5 expression during T cell receptor activation with anti-CD3 and anti-CD28. Error bars indicate SD of results
from at least five different experiments (A). Representatives of three independent experiments are shown (B and D), and results from seven different do-
nors (C) are shown.1379 Kim et al.
cles and interfollicular areas. These CD57  CD4 T cells are
also restricted to the GCs in other lymphoid tissues such as
the spleen and lymph nodes (35). This strategic localization
of GC-Th cells in lymphoid tissues is relevant to their
functions in GCs, where B cells undergo activation and dif-
ferentiation to become functional memory and antibody-
producing plasma B cells. Additionally, the localization of
GC-Th cells correlates very well with their chemotactic
phenotype: GC-Th cells express CXCR5, but not CCR7,
and chemotax well to BLC but poorly to T cell zone–che-
mokine ELC. One the other hand, as a population,
CD57 CXCR5  T cells respond equally well to ELC and
BLC, consistent with their presence in interfollicular and
follicular areas of lymphoid tissue. Tonsil CXCR5  T cells
respond only to ELC but not to BLC, suggesting their ex-
clusion from B cell areas.
Among the CD4 T cell populations in tonsils, only GC-
Th cells demonstrate efficient constitutive B cell helper ac-
tivity, supporting B cell production of IgG, IgA, and IgM.
Other CD4 T cell types, CD57 CXCR5  T cells and
CXCR5  T cells, induce only low or no secretion of IgG,
IgA, and IgM from B cells. Thus, our study reveals a fur-
ther specialization of CXCR5  T cells. The efficient B cell
help activity of GC-Th cells undoubtedly reflects a unique
effector machinery. GC-Th cells can produce cytokines
IL-10, IL-2, IL-4, IFN- , and TNF- , and surface costim-
ulatory molecules OX40 and CD40L. Consistent with
these findings, it has been reported previously that mRNA
expression of IL-4, IL-10, TNF- , and IFN-  was de-
tected by reverse transcription PCR in CD57  CD4 T cells
(44). IL-10, a cytokine important for antibody class switch-
ing and B cell differentiation into plasma cells (24), is par-
ticularly more efficiently provided by GC-Th cells than
other T cells. In this regard, it is interesting that inducible
costimulator is highly expressed on tonsillar T cells in the
apical light zone of GCs, (where CD57  GC-Th cells are
localized), and activation of inducible costimulator on T
cells superinduces the synthesis of IL-10 (45).
It is not known how blood CXCR5  T cells are related
to their lymphoid tissue counterparts. From the fact that
naive T cells quickly become CD57 CXCR5  T cells in
response to dendritic cell stimulation within 4–5 d (data
not shown), we propose that nonB cell–helping lymphoid
CD57 CXCR5  T cells may be the earliest CXCR5  T
cells freshly generated from naive T cells in response to an-
tigen and dendritic cells. Further activation of these
CD57 CXCR5  T cells may lead to more differentiated
GC-Th cells with efficient B cell helping activity. Another
possibility is that GC-Th and CD57 CXCR5  T cells are
interchangeable populations in which CD57 is upregulated
when cells receive GC-specific signal(s), and they either
apoptose or revert to a CD57 CXCR5  phenotype af-
ter the signal or antigen stimulation is cleared. Blood
CXCR5  T cells have a similar phenotype to lymphoid
CD57 CXCR5  T cells in that they are CD57  and
CCR7  and have dramatically reduced capacities to pro-
duce IL-4 and/or IFN- . Thus, it is likely that blood
CXCR5  T cells may be the recirculating counterparts of
lymphoid CD57 CXCR5  T cells. Few GC-Th cells
(CXCR5 CD57bright) are found in circulation, suggesting
that GC-Th cells stay in GCs for B cell differentiation and,
like GC B cells, do not recirculate.
In contrast to recent publications, we find that CXCR5
expression alone is not a specific indicator of Th cells for B
cell development. CXCR5  but CD57  tonsil T cells help
B cells poorly. CXCR5  and CXCR5  subsets of blood
memory CD4 T cells also do not provide help, unless they
are activated, and CXCR5  and CXCR5  T cells display
a similar potential for B helper activity after T cell receptor
stimulation. Tonsil CD57 CXCR5  cells and circulating
CXCR5  T cells, which are uniquely deficient in effector
cytokine production compared with circulating CXCR5  T
cells, may represent a precursor pool for the CD57  GC-Th
cells. Interestingly, CXCR5  T cells can quickly lose CXCR5
expression upon T cell receptor activation. Thus, CXCR5 is
not a stable marker for T cells with B helper activity.
In conclusion, based upon recent reports and our find-
ings in this paper, we hypothesize that naive CD4 T cells
upon antigen stimulation can differentiate into either
CXCR5  or CXCR5  CD4 T cells. CXCR5  CD4 T
cells can further differentiate to CD57 CXCR5  CD4 T
cells and localize in GCs to help B cell differentiation,
while CXCR5  CD4 T cells take the Th1/2 memory/ef-
fector pathway to become CD4 cells efficient in effector
cytokine production. CXCR5  CD4 T cells emigrate and
recirculate through the blood and lymphoid organs and are
relatively deficient in cells targeted to extralymphoid sites
of tissue inflammation, which reside primarily in the
CXCR5  population.
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